DK1262557T3 - Parkinprotein som ubiquitinligase - Google Patents

Parkinprotein som ubiquitinligase

Info

Publication number
DK1262557T3
DK1262557T3 DK01906293T DK01906293T DK1262557T3 DK 1262557 T3 DK1262557 T3 DK 1262557T3 DK 01906293 T DK01906293 T DK 01906293T DK 01906293 T DK01906293 T DK 01906293T DK 1262557 T3 DK1262557 T3 DK 1262557T3
Authority
DK
Denmark
Prior art keywords
ubiquitin ligase
parkin protein
parkin
protein
image
Prior art date
Application number
DK01906293T
Other languages
English (en)
Inventor
Yoshikuni Mizuno
Nobuyoshi Shimizu
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK1262557T3 publication Critical patent/DK1262557T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Noodles (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Image Processing (AREA)
DK01906293T 2000-02-24 2001-02-26 Parkinprotein som ubiquitinligase DK1262557T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000047801 2000-02-24

Publications (1)

Publication Number Publication Date
DK1262557T3 true DK1262557T3 (da) 2006-11-13

Family

ID=18569991

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01906293T DK1262557T3 (da) 2000-02-24 2001-02-26 Parkinprotein som ubiquitinligase

Country Status (10)

Country Link
US (1) US20050042607A1 (da)
EP (1) EP1262557B1 (da)
AT (1) ATE343001T1 (da)
AU (1) AU2001234171A1 (da)
CA (1) CA2398703A1 (da)
DE (1) DE60123934T2 (da)
DK (1) DK1262557T3 (da)
ES (1) ES2272444T3 (da)
MX (1) MXPA02008256A (da)
WO (1) WO2001062957A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017348B1 (en) * 2005-12-12 2011-09-13 Elan Pharma International Limited Assay for Parkinson's Disease therapeutics
JP2009519040A (ja) * 2005-12-12 2009-05-14 エラン・フアーマシユーチカルズ・インコーポレーテツド パーキンソン病治療のためのアッセイおよびそこにおいて有用な酵素的に活性のあるＰａｒｋｉｎ調製物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2257029T3 (es) * 1998-02-09 2006-07-16 Boehringer Ingelheim International Gmbh Dnas o genes que participan en la enfermedad de parkinson.
GB9826276D0 (en) * 1998-12-01 1999-01-20 Univ Leeds Therapeutic agents for use in degenerative disorders
US7070940B2 (en) * 2002-07-18 2006-07-04 Aventis Pharma S.A. Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein

Also Published As

Publication number Publication date
EP1262557A4 (en) 2003-05-02
DE60123934D1 (de) 2006-11-30
AU2001234171A1 (en) 2001-09-03
ATE343001T1 (de) 2006-11-15
MXPA02008256A (es) 2003-01-28
CA2398703A1 (en) 2001-08-30
ES2272444T3 (es) 2007-05-01
EP1262557A1 (en) 2002-12-04
DE60123934T2 (de) 2007-10-18
US20050042607A1 (en) 2005-02-24
WO2001062957A1 (fr) 2001-08-30
EP1262557B1 (en) 2006-10-18

Similar Documents

Publication Publication Date Title
BR0115124B1 (pt) dispositivo para fundir uma amostra hiperpolarizada sàlida, mÉtodo para produzir uma amostra hiperpolarizada fundida, e, uso de um dispositivo ou mÉtodo.
DE60226028D1 (de) Projektionssystem mit geringem astigmatismus
NL1021362A1 (nl) Katalysator- en oplosmiddelsamenstelling en katalysewerkwijzen waarbij deze samenstelling wordt toegepast.
DK1719511T3 (da) N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methansulfonamid, en farmaceutisk sammensætning omfattende samme, og anvendelse deraf
DE60236779D1 (de) Laserprojektionssystem
NO913524D0 (no) Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav.
DK0965578T3 (da) Hidtil ukendt triglycerik og præparat, som omfatter dette
NL1022018A1 (nl) Belichtingswerkwijze.
AU2003221102A1 (en) Projection optical system, exposure system and exposure method
DE69931201D1 (de) Photoresist copolymer.
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
DE60208598D1 (de) Toner, Bildherstellungsverfahren und Prozesskassette
DK1262557T3 (da) Parkinprotein som ubiquitinligase
NO20023412L (no) Fremgangsmåter, optiske registreringsanordninger som bruker slike fremgangsmåter og optiske registreringsmedium for bruk vedfremgangsmåtene og registreringsanordningene
DE60213084D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
ITTO20020085V0 (it) Proiettore per veicoli.
BR0202395B1 (pt) unidade de esmerilhamento, conjunto de unidades de esmerilhamento, e, método para montar um conjunto de unidades de esmerilhamento.
NL1012028A1 (nl) Aminozuursequentie.
ITTO20020066U1 (it) Proiettore per veicoli.
DE60332037D1 (de) Rotierendes molekül v1-atpase
이현숙 S kkkk
ES1048822Y (es) Mesa plegable perfeccionada.
ES1046632Y (es) Foco perfeccionado.
ES1046749Y (es) Foco empotrable perfeccionado.
HU9902074D0 (en) Optical method for the examination of flows, based on the principle of central projection